Product Information
GNP INFANT PAIN-FEVER 160 MG/5 is a generic product labeled by AmerisourceBergen, priced at $0.0406 per ML under NDC 46122076434. Its NADAC has been published 74 times since May 7, 2025.
Strength
160 mg/5mL
Manufacturer
AmerisourceBergenNDC
46122076434
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
2/7/2024
Price Statistics
The NADAC for GNP INFANT PAIN-FEVER 160 MG/5 has been published 74 times since May 7, 2025, and over the history we have for it it has declined 2.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0406 per ML |
|---|---|
| All-time high | $0.0575 (Jun 10, 2026) |
| All-time low | $0.0393 (Aug 19, 2026) |
| 52-week high | $0.0575 |
| 52-week low | $0.0393 |
| Median price | $0.0452 |
| Average price | $0.0462 |
| Largest weekly change | -15.4% (Jul 22, 2026) |
| Weeks tracked | 74 |
| Tracking since | May 7, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP INFANT PAIN-FEVER 160 MG/5?
The current National Average Drug Acquisition Cost (NADAC) for GNP INFANT PAIN-FEVER 160 MG/5, manufactured by AmerisourceBergen, is $0.0406 per ML (NDC 46122076434), effective Sep 30, 2026.
How has the price of GNP INFANT PAIN-FEVER 160 MG/5 changed over time?
Over the history we have for it, the NADAC for GNP INFANT PAIN-FEVER 160 MG/5 has declined 2.2%. It has been tracked across 74 weekly CMS publications since May 7, 2025.
What are the highest and lowest recorded NADAC prices for GNP INFANT PAIN-FEVER 160 MG/5?
Since May 7, 2025, the NADAC for GNP INFANT PAIN-FEVER 160 MG/5 has ranged from a low of $0.0393 (Aug 19, 2026) to a high of $0.0575 (Jun 10, 2026), with a median of $0.0452 per ML.
Are there cheaper alternatives to GNP INFANT PAIN-FEVER 160 MG/5?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHILD PAIN-FEVER 160 MG/5 ML, is $0.0205 per ML — about 49% below GNP INFANT PAIN-FEVER 160 MG/5.
Who manufactures GNP INFANT PAIN-FEVER 160 MG/5?
GNP INFANT PAIN-FEVER 160 MG/5 (NDC 46122076434) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.